MedTrace Logo

Broadband Collaborative Pulse Ablation Instrument Treating Malignant Pulmonary Nodules

NCT06530667 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2024-07-31

No results posted yet for this study

Summary

Effectiveness safety and feasibility of the broadband collaborative pulse ablation instrument in treating malignant pulmonary nodules

Conditions

  • Lung Neoplasm Malignant
  • Secondary Lung Cancer

Interventions

DEVICE

broadband collaborative pulse ablation

Via CT guided, patients with malignant pulmonary nodules would be treated by broadband collaborative pulse ablation

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Lingxiao Liu · Fudan University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2025-04-30
Completion
2025-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06530667 on ClinicalTrials.gov